PharmaLegacy
Preclinical Specialty Pharmacology Services
PharmaLegacy provides preclinical in vivo pharmacology and PKPD/non-GLP toxicology services.
Our state-of-the-art platforms include:
- The largest portfolio of Ophthalmic animal models in the industry
- CD34+ humanized mice to evaluate therapeutic efficacy of biologics for Immuno-oncology and Immune diseases
- A robust NHP platform for PKPD evaluation and disease models in Ophthalmology, Inflammation, and multiple Immune diseases
- Fully integrated analytical capabilities including histopathology, flow cytometry, in vivo imaging, bioanalytical analysis, and full cell and molecular biology support for your programs
In total, we offer over 600 clinically predictive animal disease models to evaluate pharmacological effects of drug candidates in the areas of Ophthalmology, Inflammation/Auto-Immune diseases, Lung injury, Liver and Metabolic diseases, Cardiovascular disease, and Oncology.
We have supported many IND filings to both FDA and CFDA (China) for therapeutic candidates in a variety of indications.
Our animal vivarium is fully accredited by AAALAC and houses species ranging from rodents, rabbits and other small animals to NHPs.